Focus Group for Smoking

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Smoking
Focus Group - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is examining whether different types of messages emphasizing the health consequences of smoking, written at a 5th to 6th grade reading level, will have different effects on smokers with varying levels of health literacy.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 years

2 years
Factors that may influence how smokers understand smoking health risk informational messages.

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Emotional Loss-Framed
1 of 4
Factual Loss-Framed
1 of 4
Emotional Gain-Framed
1 of 4
Factual Gain-Framed
1 of 4
Experimental Treatment

495 Total Participants · 4 Treatment Groups

Primary Treatment: Focus Group · No Placebo Group · N/A

Emotional Loss-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Factual Loss-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Emotional Gain-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Factual Gain-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Focus Group
2013
Completed Phase 1
~4140
Questionnaire
2014
Completed Phase 2
~20100

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,563 Total Patients Enrolled
57 Trials studying Smoking
52,176 Patients Enrolled for Smoking
M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,784,524 Total Patients Enrolled
13 Trials studying Smoking
3,937 Patients Enrolled for Smoking
Lorna H. McNeill, MPH,PHDPrincipal InvestigatorM.D. Anderson Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: October 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Texas100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
University of Texas MD Anderson Cancer Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%